Chor-Sang Chim (Chor S Chim, Chor Sang Chim)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 17

Top Venues

Bone marrow transplantation

Leukemia & lymphoma

Hematology (Amsterdam, Netherlands)

Clinical epigenetics

The University of Hong Kong

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The University of Hong Kong

Hong Kong

Clinical Professor :: Department of Medicine

Publications

Hoi Ki Karen Tang, Chi Yeung Fung, Yu Yan Hwang, Harold Lee, Grace Lau, Sze Fai Yip, Bonnie Kho, Chi Kuen Lau, Kwan Hung Leung, Elaine Au, Eric Tse, Joycelyn Sim, Yok Lam Kwong, Chor-Sang Chim
Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT, transplant refusal and high-risk MM. Bone marrow transplantation 59 (5) (2024)
Hoi Ki Karen Tang, Chi Yeung Fung, Yu Yan Hwang, Harold Lee, Grace Lau, Sze Fai Yip, Bonnie Kho, Chi Kuen Lau, Kwan Hung Leung, Elaine Au, Eric Tse, Joycelyn Sim, Yok Lam Kwong, Chor-Sang Chim
Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT, transplant refusal and high-risk MM. Bone marrow transplantation 59 (5) (2024)
Hoi Ki Karen Tang, Chi Yeung Fung, Yu Yan Hwang, Harold Lee, Grace Lau, Sze Fai Yip, Bonnie Kho, Chi Kuen Lau, Kwan Hung Leung, Elaine Au, Eric Tse, Joycelyn Sim, Yok Lam Kwong, Chor-Sang Chim
Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT, transplant refusal and high-risk MM. Bone marrow transplantation 59 (5) (2024)
Hoi Ki Karen Tang, Chi Yeung Fung, Yu Yan Hwang, Harold Lee, Grace Lau, Sze Fai Yip, Bonnie Kho, Chi Kuen Lau, Kwan Hung Leung, Elaine Au, Eric Tse, Joycelyn Sim, Yok Lam Kwong, Chor-Sang Chim
Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT, transplant refusal and high-risk MM. Bone marrow transplantation (2024)
Hoi Ki Karen Tang, Chi Yeung Fung, Yu Yan Hwang, Harold Lee, Grace Lau, Sze Fai Yip, Bonnie Kho, Chi Kuen Lau, Kwan Hung Leung, Elaine Au, Eric Tse, Joycelyn Sim, Yok Lam Kwong, Chor-Sang Chim
Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT, transplant refusal and high-risk MM. Bone marrow transplantation 59 (5) (2024)
Hoi Ki Karen Tang, Chi Yeung Fung, Gareth J Morgan, Shaji K Kumar, Lisa Siu, Ho Wan Alvin Ip, Sze Fai Yip, Ka Ngai Harry Lau, Chi Kuen Lau, Harold Lee, Kwan Hung Leung, Bonnie Kho, Howard Wong, Cheong Ngai, Yu Yan Hwang, Joycelyn Sim, Yok Lam Kwong, Chor-Sang Chim
The impact of bortezomib-based induction in newly diagnosed multiple myeloma with chromosome 1q21 gain. Therapeutic advances in hematology 13 (2022)
Chor-Sang Chim, Shaji K Kumar, Vincent Kai Chung Wong, Michael Cheong Ngai, Yok Lam Kwong
3-weekly daratumumab-lenalidomide/pomalidomide-dexamethasone is highly effective in relapsed and refractory multiple myeloma. Hematology (Amsterdam, Netherlands) 26 (1) (2021)
Min Yue Zhang, Lu Qian Wang, Chor-Sang Chim
miR-1250-5p is a novel tumor suppressive intronic miRNA hypermethylated in non-Hodgkin's lymphoma: novel targets with impact on ERK signaling and cell migration. Cell communication and signaling : CCS 19 (1) (2021)
Artur Jurczyszyn, Anna Waszczuk-Gajda, Jorge J Castillo, Katarzyna Krawczyk, Martin Stork, Ludek Pour, Lidia Usnarska-Zubkiewicz, Stanisław Potoczek, Iwona Hus, Julio Davila Valls, Parameswaran Hari, Saurabh Chhabra, Massimo Gentile, Gabor Mikala, Gergely Varga, Chor-Sang Chim, Mark Fiala, Ravi Vij, Natalia Schutz, Marek Rodzaj, Agnieszka Porowska, David H Vesole, Agnieszka Druzd-Sitek, Jan Walewski, Ajay K Nooka
Primary refractory multiple myeloma: a real-world experience with 85 cases. Leukemia & lymphoma 61 (12) (2020)
Sarah Goldman-Mazur, Artur Jurczyszyn, Jorge J Castillo, Anna Waszczuk-Gajda, Norbert Grząśko, Jakub Radocha, Max Bittrich, K Martin Kortüm, Alessandro Gozzetti, Lidia Usnarska-Zubkiewicz, Julio Davila Valls, David S Jayabalan, Ruben Niesvizky, Julia Kelman, Daniel Coriu, Laura Rosiñol, Łukasz Szukalski, Veronica González-Calle, Maria V Mateos, Krzysztof Jamroziak, Iwona Hus, Irit Avivi, Yael C Cohen, Anna Suska, Aimee Chappell, Deepu Madduri, Saurabh Chhabra, Ariel Kleman, Parameswaran Hari, Michel Delforge, Paweł Robak, Massimo Gentile, Izabela Kozłowska, Stuart L Goldberg, Jacek Czepiel, Rebecca Silbermann, Adam J Olszewski, Peter Barth, Gabor Mikala, Chor-Sang Chim, Monika Długosz-Danecka, Sebastian Grosicki, David H Vesole
A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma. American journal of hematology 95 (5) (2020)
Thomas S Y Chan, Yu-Yan Hwang, Pek-Lan Khong, Anskar Y H Leung, Chor-Sang Chim, Eric W C Tse, Yok Lam Kwong
Low-dose pembrolizumab and nivolumab were efficacious and safe in relapsed and refractory classical Hodgkin lymphoma: Experience in a resource-constrained setting. Hematological oncology 38 (5) (2020)
Zhenhai Li, Shaji Kumar, Dong-Yan Jin, George A Calin, Wee-Joo Chng, Kam-Leung Siu, Ming-Wai Poon, Chor-Sang Chim
Epigenetic silencing of long non-coding RNA BM742401 in multiple myeloma: impact on prognosis and myeloma dissemination. Cancer cell international 20 (2020)
Kwan Yeung Wong, Chor-Sang Chim
Venetoclax, bortezomib and S63845, an MCL1 inhibitor, in multiple myeloma. The Journal of pharmacy and pharmacology 72 (5) (2020)
Sarah Goldman-Mazur, Artur Jurczyszyn, Jorge J Castillo, Anna Waszczuk-Gajda, Norbert Grząśko, Jakub Radocha, Max Bittrich, Klaus Martin Kortüm, Alessandro Gozzetti, Lidia Usnarska-Zubkiewicz, Julio D Valls, David S Jayabalan, Ruben Niesvizky, Julia Kelman, Daniel Coriu, Laura Rosinol, Łukasz Szukalski, Veronica González-Calle, Maria-Victoria Mateos-Manteca, Krzysztof Jamroziak, Iwona Hus, Irit Avivi, Yael C Cohen, Piotr K Mazur, Anna Suska, Aimee Chappell, Deepu Madduri, Saurabh Chhabra, Ariel Kleman, Parameswaran Hari, Michel Delforge, Paweł Robak, Massimo Gentile, Izabela Kozłowska, Stuart L Goldberg, Jacek Czepiel, Monika Długosz-Danecka, Rebecca Silbermann, Adam J Olszewski, Peter Barth, Gabor Mikala, Chor-Sang Chim, David H Vesole
Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients. Leukemia & lymphoma 61 (8) (2020)
Min Yue Zhang, George A Calin, Kit San Yuen, Dong Yan Jin, Chor-Sang Chim
Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy. Clinical epigenetics 12 (1) (2020)
Yinlei Bai, Chor-Sang Chim
Ficolled bone marrow is superior to bone marrow buffy coat for detection of minimal residual disease in multiple myeloma. Hematology (Amsterdam, Netherlands) 24 (1) (2019)
Kwan Yeung Wong, Qiumei Yao, Ling-Qing Yuan, Zhenhai Li, Edmond Shiu Kwan Ma, Chor-Sang Chim
Frequent functional activation of RAS signalling not explained by RAS/RAF mutations in relapsed/refractory multiple myeloma. Scientific reports 8 (1) (2018)

Chor-Sang Chim.css-eqlu8i{font-size:small;padding-left:4px;} (Chor S Chim, Chor Sang Chim)

Publication Activity (10 Years)

Top Topics

Top Venues

Chor-Sang Chim (Chor S Chim, Chor Sang Chim)